We create bespoke proteins
for breakthrough medicines

We create
bespoke proteins
for breakthrough medicines

Our team bridges the best in AI and biology, with deep experience at leading institutions.

Our Team

Our Team

Leadership

Leadership

Ali Madani
CEO

Hilary Eaton
CBO

Peter Cameron
VP & Head of Gene Editing

Board

Board

Ali Madani

Fraser Kelton

Nabeel Hyatt

Dylan Morris

Aiden Aceves

Nathan Benaich

Advisors

Advisors

Richard Socher

James Fraser

Alexander Meeske

Driving innovation with our investors.

Driving innovation
with our investors.

Driving innovation
with our investors.

Back to Top

Back to Top